Hypercalcemia (Ca >12 mg/dL) at diagnosis — hallmark of aggressive ATLL; requires bisphos...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-ATLL-ORGAN-DYSFUNCTION |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-25 | pending_clinical_signoff |
| Diseases | DIS-ATLL |
| Sources | SRC-ESMO-PTCL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Hypercalcemia (Ca >12 mg/dL) at diagnosis — hallmark of aggressive ATLL; requires bisphosphonate/calcitonin urgently and predicts aggressive subtype regardless of WBC. |
|---|---|
| Clinical direction | intensify |
| Category | organ-dysfunction |
| Shifts algorithm | ALGO-ATLL-1L |
Trigger Logic
{
"any_of": [
{
"comparator": ">",
"finding": "calcium_mg_dl",
"threshold": 12
},
{
"finding": "atll_hypercalcemia",
"value": true
}
],
"type": "lab_value"
}
Notes
Hypercalcemia in ATLL is paraneoplastic (RANKL-driven by HTLV-1+ T cells) — its presence overrides Shimoyama subtyping toward aggressive variant; AZT+IFN-α inadequate. Immediate hypercalcemia management + aggressive chemo (mLSG-15 / EPOCH-like) standard.
Used By
Algorithms
ALGO-ATLL-1L- ALGO-ATLL-1L
Red flag
RF-ATLL-SHIMOYAMA-INDOLENT- Shimoyama smoldering or chronic-favourable subtype of ATLL. Smoldering: ≥5% circulating a...